SEC Form 4 · accession 0001179022-17-000070
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin D Freeman
Director
Period of report
Dec 7, 2017
Accepted (ET)
Dec 8, 2017 · 2:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2017 | P | 8,000 | $1.6256 | A | 8,000 | I | IRA |
| Common Stock | Dec 7, 2017 | P | 400 | $1.6433 | A | 28,043 | D |
Table II — derivative securities
No Table II lines on this filing.